94 related articles for article (PubMed ID: 25522987)
1. Regulation of HDL genes: transcriptional, posttranscriptional, and posttranslational.
Kardassis D; Gafencu A; Zannis VI; Davalos A
Handb Exp Pharmacol; 2015; 224():113-79. PubMed ID: 25522987
[TBL] [Abstract][Full Text] [Related]
2. Genetic variants in ABCA1 promoter affect transcription activity and plasma HDL level in pigs.
Dang XY; Chu WW; Shi HC; Yu SG; Han HY; Gu SH; Chen J
Gene; 2015 Jan; 555(2):414-20. PubMed ID: 25445391
[TBL] [Abstract][Full Text] [Related]
3. Molecular mechanisms underlying statin effects on genes involved in the reverse cholesterol transport.
Cerda A; Hirata MH; Hirata RD
Drug Metabol Drug Interact; 2012 May; 27(2):101-11. PubMed ID: 22706233
[TBL] [Abstract][Full Text] [Related]
4. Genetics and regulation of HDL metabolism.
Kardassis D; Thymiakou E; Chroni A
Biochim Biophys Acta Mol Cell Biol Lipids; 2022 Jan; 1867(1):159060. PubMed ID: 34624513
[TBL] [Abstract][Full Text] [Related]
5. Regulation of high-density lipoprotein metabolism.
Rye KA; Barter PJ
Circ Res; 2014 Jan; 114(1):143-56. PubMed ID: 24385508
[TBL] [Abstract][Full Text] [Related]
6. miRNAs and High-Density Lipoprotein metabolism.
Baldán Á; de Aguiar Vallim TQ
Biochim Biophys Acta; 2016 Dec; 1861(12 Pt B):2053-2061. PubMed ID: 26869447
[TBL] [Abstract][Full Text] [Related]
7. Inflammation alters HDL composition and function: implications for HDL-raising therapies.
Marsche G; Saemann MD; Heinemann A; Holzer M
Pharmacol Ther; 2013 Mar; 137(3):341-51. PubMed ID: 23246719
[TBL] [Abstract][Full Text] [Related]
8. Effects of hypolipidemic drugs on the expression of genes involved in high density lipoprotein metabolism in the rat.
Staels B; Van Tol A; Fruchart JC; Auwerx J
Isr J Med Sci; 1996 Jun; 32(6):490-8. PubMed ID: 8682657
[TBL] [Abstract][Full Text] [Related]
9. Micro-RNAs and High-Density Lipoprotein Metabolism.
Canfrán-Duque A; Lin CS; Goedeke L; Suárez Y; Fernández-Hernando C
Arterioscler Thromb Vasc Biol; 2016 Jun; 36(6):1076-84. PubMed ID: 27079881
[TBL] [Abstract][Full Text] [Related]
10. High-density lipoproteins: multifunctional vanguards of the cardiovascular system.
Marcil M; O'Connell B; Krimbou L; Genest J
Expert Rev Cardiovasc Ther; 2004 May; 2(3):417-30. PubMed ID: 15151487
[TBL] [Abstract][Full Text] [Related]
11. Fetal HDL/apoE: a novel regulator of gene expression in human placental endothelial cells.
Augsten M; Hackl H; Ebner B; Chemelli A; Glatter O; Marsche G; Lang U; Desoye G; Wadsack C
Physiol Genomics; 2011 Nov; 43(22):1255-62. PubMed ID: 21954452
[TBL] [Abstract][Full Text] [Related]
12. Effects of oral contraceptives on lipid metabolism.
Krauss RM
J Reprod Med; 1986 Jun; 31(6 Suppl):549-50. PubMed ID: 3723487
[TBL] [Abstract][Full Text] [Related]
13. [Concerning the significance of paraoxonase-1 and SR-B1 genes in atherosclerosis].
Rodríguez Esparragón F; Hernández Trujillo Y; Macías Reyes A; Hernández Ortega E; Medina A; Rodríguez Pérez JC
Rev Esp Cardiol; 2006 Feb; 59(2):154-64. PubMed ID: 16540037
[TBL] [Abstract][Full Text] [Related]
14. Nephrotic syndrome causes upregulation of HDL endocytic receptor and PDZK-1-dependent downregulation of HDL docking receptor.
Vaziri ND; Gollapudi P; Han S; Farahmand G; Yuan J; Rahimi A; Moradi H
Nephrol Dial Transplant; 2011 Oct; 26(10):3118-23. PubMed ID: 21459782
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA regulation of cholesterol metabolism.
Citrin KM; Fernández-Hernando C; Suárez Y
Ann N Y Acad Sci; 2021 Jul; 1495(1):55-77. PubMed ID: 33521946
[TBL] [Abstract][Full Text] [Related]
16. Transfer of lipids to high-density lipoprotein (HDL) is altered in patients with familial hypercholesterolemia.
Martinez LR; Santos RD; Miname MH; Deus DF; Lima ES; Maranhão RC
Metabolism; 2013 Aug; 62(8):1061-4. PubMed ID: 23540443
[TBL] [Abstract][Full Text] [Related]
17. Identification of novel human high-density lipoprotein receptor Up-regulators using a cell-based high-throughput screening assay.
Yang Y; Zhang Z; Jiang W; Gao L; Zhao G; Zheng Z; Wang M; Si S; Hong B
J Biomol Screen; 2007 Mar; 12(2):211-9. PubMed ID: 17259591
[TBL] [Abstract][Full Text] [Related]
18. High-density lipoproteins in the prevention of cardiovascular disease: changing the paradigm.
Tuteja S; Rader DJ
Clin Pharmacol Ther; 2014 Jul; 96(1):48-56. PubMed ID: 24713591
[TBL] [Abstract][Full Text] [Related]
19. Apolipoprotein A-II is a key regulatory factor of HDL metabolism as appears from studies with transgenic animals and clinical outcomes.
Maïga SF; Kalopissis AD; Chabert M
Biochimie; 2014 Jan; 96():56-66. PubMed ID: 24012775
[TBL] [Abstract][Full Text] [Related]
20. In search of new targets for plasma high-density lipoprotein cholesterol levels: promise of human-mouse comparative genomics.
Rollins J; Chen Y; Paigen B; Wang X
Trends Cardiovasc Med; 2006 Oct; 16(7):220-34. PubMed ID: 16980179
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
